Pox proteomics: mass spectrometry analysis and identification of Vaccinia virion proteins.
about
Vaccinia virus 4c (A26L) protein on intracellular mature virus binds to the extracellular cellular matrix lamininComparison of the Cowpox Virus and Vaccinia Virus Mature Virion Proteome: Analysis of the Species- and Strain-Specific ProteomeGeneration of a complete single-gene knockout bacterial artificial chromosome library of cowpox virus and identification of its essential genesVaccinia viral protein A27 is anchored to the viral membrane via a cooperative interaction with viral membrane protein A17Simultaneous Quantification of Viral Antigen Expression Kinetics Using Data-Independent (DIA) Mass Spectrometry.A novel cellular protein, VPEF, facilitates vaccinia virus penetration into HeLa cells through fluid phase endocytosis.Disulfide bond formation at the C termini of vaccinia virus A26 and A27 proteins does not require viral redox enzymes and suppresses glycosaminoglycan-mediated cell fusion.Proteomic basis of the antibody response to monkeypox virus infection examined in cynomolgus macaques and a comparison to human smallpox vaccination.Mimivirus giant particles incorporate a large fraction of anonymous and unique gene products.Human CD4+ T cell epitopes from vaccinia virus induced by vaccination or infectionMulti-faceted proteomic characterization of host protein complement of Rift Valley fever virus virions and identification of specific heat shock proteins, including HSP90, as important viral host factorsGlobal approaches to study protein-protein interactions among viruses and hostsHuman antibody responses to the polyclonal Dryvax vaccine for smallpox prevention can be distinguished from responses to the monoclonal replacement vaccine ACAM2000.Mass spectrometric analysis of multiple pertussis toxins and toxoids.Genes in the terminal regions of orthopoxvirus genomes experience adaptive molecular evolutionProteome analysis of vaccinia virus IHD-W-infected HEK 293 cells with 2-dimensional gel electrophoresis and MALDI-PSD-TOF MS of on solid phase support N-terminally sulfonated peptides.Structure/Function analysis of the vaccinia virus F18 phosphoprotein, an abundant core component required for virion maturation and infectivity.The neutralizing antibody response to the vaccinia virus A28 protein is specifically enhanced by its association with the H2 proteinDefinition of epitopes and antigens recognized by vaccinia specific immune responses: their conservation in variola virus sequences, and use as a model system to study complex pathogensParticipation of vaccinia virus l2 protein in the formation of crescent membranes and immature virions.Interaction between the G3 and L5 proteins of the vaccinia virus entry-fusion complex.Smallpox vaccines: targets of protective immunity.Measurement of antibody responses to Modified Vaccinia virus Ankara (MVA) and Dryvax(®) using proteome microarrays and development of recombinant protein ELISAsTranscriptional repression and RNA silencing act synergistically to demonstrate the function of the eleventh component of the vaccinia virus entry-fusion complex.Uncovering the interplay between CD8, CD4 and antibody responses to complex pathogens.Integrin β1 mediates vaccinia virus entry through activation of PI3K/Akt signaling.Antibody profiling by proteome microarray reveals the immunogenicity of the attenuated smallpox vaccine modified vaccinia virus ankara is comparable to that of Dryvax.Vaccinia virus E2L null mutants exhibit a major reduction in extracellular virion formation and virus spread.Comparative proteomics of human monkeypox and vaccinia intracellular mature and extracellular enveloped virionsViral proteomics.Vaccinia virus l1 protein is required for cell entry and membrane fusion.Vaccinia virus WR53.5/F14.5 protein is a new component of intracellular mature virus and is important for calcium-independent cell adhesion and vaccinia virus virulence in miceVaccinia virus encodes I5, a small hydrophobic virion membrane protein that enhances replication and virulence in mice.Vaccinia virus A26 and A27 proteins form a stable complex tethered to mature virions by association with the A17 transmembrane protein.Viral proteomics: global evaluation of viruses and their interaction with the host.Orthopoxvirus targets for the development of new antiviral agents.The polyadenylation site of Mimivirus transcripts obeys a stringent 'hairpin rule'.Vaccinia virus A19 protein participates in the transformation of spherical immature particles to barrel-shaped infectious virions.Expression of the highly conserved vaccinia virus E6 protein is required for virion morphogenesis.Characterization of a newly identified 35-amino-acid component of the vaccinia virus entry/fusion complex conserved in all chordopoxviruses.
P2860
Q24336532-86A0F157-43B7-426B-933B-3B1FDE029133Q28550799-B4B2B0B7-9959-4701-9265-7376DBC8F96AQ28659589-6C657063-DF91-46B8-820A-6D7FA0A6F54BQ30358168-BBADC8B3-12D6-4A1F-8169-532D4F33709BQ30372565-F8DEAE08-7F2D-4BE7-B29C-12DE37D0FBDAQ30483178-CF6B04B4-6B3B-4699-8D31-7298D7CCE019Q30488301-C40AE13F-EF4B-4A2D-AA32-E8E567A44792Q30994031-AC97D1B6-EC18-451B-B47A-2AD092908FD6Q33257519-4A840E42-22EF-4713-98DF-9D60F29DC510Q33302672-43BCA5E5-1B9B-467C-BE7C-9526758C60ADQ33583806-B75C2F21-0763-481B-94A2-0D7F49BFB15BQ33703278-99690B98-E668-41DA-9C1D-4D4AF8513BE3Q33743444-102AEC6A-4CE7-4410-B0B4-ABFAA95EE03FQ33871073-A3B76618-9892-4C3A-A07F-C2D5BF42660CQ33909381-5FB4F269-BF82-4E36-A919-4C1F69256CE5Q33977645-2644F5BF-7DD9-4479-AF4C-383DF7D63ADDQ33990733-4D1B175B-E50B-4AEF-BCBB-D1394B26683AQ34039477-6DEDC2E2-838F-46AE-BFC1-D45C86C46C96Q34085985-5B4AA98D-C284-4583-BB8A-BEBBCFE62236Q34742862-5E918B3F-830D-4CE5-AC03-B4CE829C95B8Q34778139-C32BDD7D-5F34-4F78-8351-7C13DB10CCD2Q34780607-1618CEED-4C21-41DB-81EC-563F5D24A1C2Q35634159-F9E83654-6188-4B5D-B15C-832A7B91A6BFQ35665944-234CD757-7976-4CC6-A974-5F02A53B30E3Q35998125-F16996BC-F508-4574-A029-9123EF244383Q36086790-8E9B7CCD-82CA-4F71-80EC-B8FE812B2E20Q36424513-66F76F5E-F00C-4B35-BD9A-92359E0386EAQ36540095-30A0ED6F-9AAF-452D-A743-4F0A0DBBABCCQ36839627-E77AA68C-B063-4F91-9229-5CADB3757487Q36842301-74BFD0A5-ABDC-4ABF-8C23-02821627EAF1Q36845831-7D205E84-0DE4-4040-84EF-8B1A13CE0627Q36933959-AEDECEA8-9F70-4032-AC20-AC6F4D61C94AQ36933977-B2B33860-5BED-440A-A8FC-01A0D4A0772DQ36994647-C194C1D3-5544-4B0F-980E-E1373B2233B7Q37027508-2FEC3E0D-FC9C-466B-8C14-F7E8FD3300FDQ37173398-A932B5B1-5645-4460-AD9E-553A8423DA9CQ37247022-1685F471-9EEA-4C21-BE14-A9A30476A283Q37252836-B8E48D17-802F-4172-8217-2BCF64709D06Q37272638-B7B37336-4E1B-46E0-BABA-09698C839E3EQ37452527-C0D66223-E39E-4189-85D2-310397E4BB6F
P2860
Pox proteomics: mass spectrometry analysis and identification of Vaccinia virion proteins.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Pox proteomics: mass spectrome ...... n of Vaccinia virion proteins.
@ast
Pox proteomics: mass spectrome ...... n of Vaccinia virion proteins.
@en
type
label
Pox proteomics: mass spectrome ...... n of Vaccinia virion proteins.
@ast
Pox proteomics: mass spectrome ...... n of Vaccinia virion proteins.
@en
prefLabel
Pox proteomics: mass spectrome ...... n of Vaccinia virion proteins.
@ast
Pox proteomics: mass spectrome ...... n of Vaccinia virion proteins.
@en
P2093
P2860
P356
P1433
P1476
Pox proteomics: mass spectrometry analysis and identification of Vaccinia virion proteins
@en
P2093
Cliff R Gagnier
Dennis E Hruby
Jennifer D Yoder
Srilakshmi Vemulapalli
Tsefang S Chen
P2860
P2888
P356
10.1186/1743-422X-3-10
P577
2006-03-01T00:00:00Z
P6179
1017377037